BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12688636)

  • 1. Effects of cytotoxic agents on functional integrity and antioxidant enzymes in clonal beta-cells.
    Picton SF; McCluskey JT; Flatt PR; McClenaghan NH
    Diabetes Metab; 2002 Dec; 28(6 Pt 2):3S70-7; discussion 3S108-12. PubMed ID: 12688636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iterative exposure of clonal BRIN-BD11 cells to ninhydrin enables selection of robust toxin-resistant cells but with decreased gene expression of insulin secretory function.
    Liu HK; McCluskey JT; McClenghan NH; Flatt PR
    Pancreas; 2008 Apr; 36(3):294-301. PubMed ID: 18362844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complementary action of antioxidant enzymes in the protection of bioengineered insulin-producing RINm5F cells against the toxicity of reactive oxygen species.
    Tiedge M; Lortz S; Munday R; Lenzen S
    Diabetes; 1998 Oct; 47(10):1578-85. PubMed ID: 9753295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hexose recognition by insulin-secreting BRIN-BD11 cells.
    McClenaghan NH; Gray AM; Barnett CR; Flatt PR
    Biochem Biophys Res Commun; 1996 Jun; 223(3):724-8. PubMed ID: 8687464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the imidazoline binding site ligands, idazoxan and efaroxan, on the viability of insulin-secreting BRIN-BD11 cells.
    Gao H; Mourtada M; Morgan NG
    JOP; 2003 May; 4(3):117-24. PubMed ID: 12743417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scoparia dulcis, a traditional antidiabetic plant, protects against streptozotocin induced oxidative stress and apoptosis in vitro and in vivo.
    Latha M; Pari L; Sitasawad S; Bhonde R
    J Biochem Mol Toxicol; 2004; 18(5):261-72. PubMed ID: 15549711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells.
    Tiedge M; Lortz S; Drinkgern J; Lenzen S
    Diabetes; 1997 Nov; 46(11):1733-42. PubMed ID: 9356019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Streptozotocin and alloxan-based selection improves toxin resistance of insulin-producing RINm cells.
    Bloch KO; Zemel R; Bloch OV; Grief H; Vardi P
    Int J Exp Diabetes Res; 2000; 1(3):211-9. PubMed ID: 11467412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Streptozotocin-resistant BRIN-BD11 cells possess wide spectrum of toxin tolerance and enhanced insulin-secretory capacity.
    Liu HK; McCluskey JT; McClenghan NH; Flatt PR
    Endocrine; 2007 Aug; 32(1):20-9. PubMed ID: 17992598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering cultured insulin-secreting pancreatic B-cell lines.
    McClenaghan NH; Flatt PR
    J Mol Med (Berl); 1999 Jan; 77(1):235-43. PubMed ID: 9930971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in the expression of heat-shock proteins and antioxidant enzymes between human and rodent pancreatic islets: implications for the pathogenesis of insulin-dependent diabetes mellitus.
    Welsh N; Margulis B; Borg LA; Wiklund HJ; Saldeen J; Flodström M; Mello MA; Andersson A; Pipeleers DG; Hellerström C
    Mol Med; 1995 Nov; 1(7):806-20. PubMed ID: 8612203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and functional activity of PPARgamma in pancreatic beta cells.
    Welters HJ; McBain SC; Tadayyon M; Scarpello JH; Smith SA; Morgan NG
    Br J Pharmacol; 2004 Aug; 142(7):1162-70. PubMed ID: 15237101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the electrogenic Na+-HCO3--cotransporter NBCe1 in tumoral insulin-producing BRIN-BD11 cells.
    Bulur N; Virreira M; Soyfoo MS; Louchami K; Delporte C; Perret J; Beauwens R; Malaisse WJ; Sener A
    Cell Physiol Biochem; 2009; 24(3-4):187-92. PubMed ID: 19710533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of hydrogen peroxide and failure of antioxidative responses in pancreatic islets of male C57BL/6 mice are associated with diabetes induced by multiple low doses of streptozotocin.
    Friesen NT; Büchau AS; Schott-Ohly P; Lgssiar A; Gleichmann H
    Diabetologia; 2004 Apr; 47(4):676-85. PubMed ID: 15298345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-cell maturation leads to in vitro sensitivity to cytotoxins.
    Nielsen K; Karlsen AE; Deckert M; Madsen OD; Serup P; Mandrup-Poulsen T; Nerup J
    Diabetes; 1999 Dec; 48(12):2324-32. PubMed ID: 10580420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major species differences between humans and rodents in the susceptibility to pancreatic beta-cell injury.
    Eizirik DL; Pipeleers DG; Ling Z; Welsh N; Hellerström C; Andersson A
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9253-6. PubMed ID: 7937750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different sensitivity to the cytotoxic action of IAPP fibrils in two insulin-producing cell lines, HIT-T15 and RINm5F cells.
    Janciauskiene S; Ahrén B
    Biochem Biophys Res Commun; 1998 Oct; 251(3):888-93. PubMed ID: 9791005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of insulin-producing RINm5F cells against cytokine-mediated toxicity through overexpression of antioxidant enzymes.
    Lortz S; Tiedge M; Nachtwey T; Karlsen AE; Nerup J; Lenzen S
    Diabetes; 2000 Jul; 49(7):1123-30. PubMed ID: 10909968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of BB rat beta cells as determined by dose-responses to the cytotoxic effects of streptozotocin and alloxan.
    Yale JF; Grose M; Videtic GM; Marliss EB
    Diabetes Res; 1986 Mar; 3(3):161-7. PubMed ID: 2940045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a novel glucose-responsive insulin-secreting cell line, BRIN-BD11, produced by electrofusion.
    McClenaghan NH; Barnett CR; Ah-Sing E; Abdel-Wahab YH; O'Harte FP; Yoon TW; Swanston-Flatt SK; Flatt PR
    Diabetes; 1996 Aug; 45(8):1132-40. PubMed ID: 8690162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.